ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Consun Pharmaceutical Group Ltd (PK)

Consun Pharmaceutical Group Ltd (PK) (CPHGF)

1,65
0,00
(0,00%)
Geschlossen 23 Juni 10:00PM

Consun Pharmaceutical Group Ltd (PK) (CPHGF) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
1,65
( - )
Gebot
0,01
Fragen
12.002,13
Volumen
-
0,00 Tagesbereich 0,00
1,12 52-Wochen-Bereich 2,00
Marktkapitalisierung
Handelsende
1,65
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 1.788.377
Ausgegebene Aktien
841.547.111
Dividendenrendite (LTM)
0,66
Kurs-Gewinn-Verhältnis
9,12
Gewinn pro Aktie (EPS)
1,26
Erlöse (LTM)
3,42B
Nettogewinn (LTM)
1,08B

Über Consun Pharmaceutical Group Ltd (PK)

Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China. It operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granules for chronic renal failure; Yishen Huashi p... Consun Pharmaceutical Group Limited, together with its subsidiaries, produces and sells pharmaceutical products in Mainland China. It operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granules for chronic renal failure; Yishen Huashi particles for proteinuria; TCM to treat diabetic kidney disease; Gadopentetate Dimeglumine injections for nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; Iopamidol injections for neuroradiology, angiography, and urography; and ultrasonic microbubble contrast agent products. It also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yuan, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis; Gyn Antidysmenorrheic tablets for irregular menstruation, period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion to treat staphylococcus aureus, candida albicans, and escherichia coli in the feminine vaginal. In addition, the company offers bone-setting liquid; Yunxiang analgesic tincture to treat rheumatism, common cold, headache, stomachache, cardiodynia, and pain in the gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease; hepatobiliary products, such as Jigucao, Compound Jigucao, and Qinggan tablets, as well as Jigucao Ganyan and Wujun Zhidan granules; and gastroenterology medicines, tonics, and other medicines. Consun Pharmaceutical Group Limited was founded in 1997 and is headquartered in Guangzhou, the People’s Republic of China. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
Guangzhou, China
Gegründet
1997
Consun Pharmaceutical Group Ltd (PK) is listed in the Healthcare sector of the OTC Markets with ticker CPHGF. The last closing price for Consun Pharmaceutical (PK) was US$1,65. Over the last year, Consun Pharmaceutical (PK) shares have traded in a share price range of US$ 1,12 to US$ 2,00.

Consun Pharmaceutical (PK) currently has 841.547.111 shares in issue. The market capitalisation of Consun Pharmaceutical (PK) is US$1,39 billion. Consun Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of 9.12.

CPHGF Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
12001.651.651.6500CS
26-0.35-17.5221.651251.825CS
520.5347.32142857141.1221.12501.825CS
1560.606658.13686026451.043421.0434128701.04707568CS
2600.606658.13686026451.043421.0434128701.04707568CS

CPHGF - Frequently Asked Questions (FAQ)

What is the current Consun Pharmaceutical Group Ltd (PK) share price?
The current share price of Consun Pharmaceutical Group Ltd (PK) is US$ 1,65
How many Consun Pharmaceutical Group Ltd (PK) shares are in issue?
Consun Pharmaceutical Group Ltd (PK) has 841.547.111 shares in issue
What is the market cap of Consun Pharmaceutical Group Ltd (PK)?
The market capitalisation of Consun Pharmaceutical Group Ltd (PK) is USD 1,39B
What is the 1 year trading range for Consun Pharmaceutical Group Ltd (PK) share price?
Consun Pharmaceutical Group Ltd (PK) has traded in the range of US$ 1,12 to US$ 2,00 during the past year
What is the PE ratio of Consun Pharmaceutical Group Ltd (PK)?
The price to earnings ratio of Consun Pharmaceutical Group Ltd (PK) is 9,12
What is the cash to sales ratio of Consun Pharmaceutical Group Ltd (PK)?
The cash to sales ratio of Consun Pharmaceutical Group Ltd (PK) is 2,83
What is the registered address of Consun Pharmaceutical Group Ltd (PK)?
The registered address for Consun Pharmaceutical Group Ltd (PK) is 71, Dongpeng Avenue, Guangzhou, Guangdong Province
What is the Consun Pharmaceutical Group Ltd (PK) website address?
The website address for Consun Pharmaceutical Group Ltd (PK) is chinaconsun.com
Which industry sector does Consun Pharmaceutical Group Ltd (PK) operate in?
Consun Pharmaceutical Group Ltd (PK) operates in the Pharmaceuticals sector

CPHGF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen